Add to ORKGPharmaceutical compositions comprise as the active ingredient potent orally active, nonneurotoxic anticonvulsant compounds that are excitatory amino acid and NMDA/sigma receptor antagonists . . . To read the remainder of this abstract, please download this patent
N-n-Alkylation of nicotine converts nicotine from an agonist into an antagonist specifically for neu...
8 pages, 8 figures, 1 table.-- PMID: 11907154 [PubMed].Excitotoxicity has been implicated in the eti...
The structure-activity relationship (SAR) for the N-benzyl group in the clinical antiepileptic agent...
Functional amino acids (FAAs) and α-aminoamides (AAAs) are two classes of antiepileptic drugs (AEDs)...
Epilepsy is a disorder characterized by the occurrence of seizures, which are periods of abnormally ...
Compounds used for treating dependence on or withdrawal from a drug of abuse, for an eating disorder...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
The present invention provides pharmaceutical preparations and the uses thereof for preventing and/o...
N-methyl-D-aspartate receptors (NMDAR) play a central role in epileptogensis and NMDAR antagonists h...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
Glutamic and aspartic acids are considered to be potent excitatory amino acid neurotransmitters of v...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
Background and Aim. Epilepsy is the most common neurological disorder after stroke. Ellagic acid (EA...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
Primary Amino Acid Derivatives (PAADs) (N′-benzyl 2-substituted 2-amino acetamides) are structurally...
N-n-Alkylation of nicotine converts nicotine from an agonist into an antagonist specifically for neu...
8 pages, 8 figures, 1 table.-- PMID: 11907154 [PubMed].Excitotoxicity has been implicated in the eti...
The structure-activity relationship (SAR) for the N-benzyl group in the clinical antiepileptic agent...
Functional amino acids (FAAs) and α-aminoamides (AAAs) are two classes of antiepileptic drugs (AEDs)...
Epilepsy is a disorder characterized by the occurrence of seizures, which are periods of abnormally ...
Compounds used for treating dependence on or withdrawal from a drug of abuse, for an eating disorder...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
The present invention provides pharmaceutical preparations and the uses thereof for preventing and/o...
N-methyl-D-aspartate receptors (NMDAR) play a central role in epileptogensis and NMDAR antagonists h...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
Glutamic and aspartic acids are considered to be potent excitatory amino acid neurotransmitters of v...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
Background and Aim. Epilepsy is the most common neurological disorder after stroke. Ellagic acid (EA...
Anticonvulsant compositions comprise as the active ingredient a compound . . . To see the remainder ...
Primary Amino Acid Derivatives (PAADs) (N′-benzyl 2-substituted 2-amino acetamides) are structurally...
N-n-Alkylation of nicotine converts nicotine from an agonist into an antagonist specifically for neu...
8 pages, 8 figures, 1 table.-- PMID: 11907154 [PubMed].Excitotoxicity has been implicated in the eti...
The structure-activity relationship (SAR) for the N-benzyl group in the clinical antiepileptic agent...